63 reports

  • ALLERGY RHINITIS DRUGS MARKET IN APAC
  • ALLERGY RHINITIS DRUGS MARKET IN EMEA

About Allergy Rhinitis Drugs Allergic rhinitis refers to the inflammation of nasal membranes that causes nasal congestion, sneezing, itching, and rhinorrhea. This condition is usually caused by dust, animal dander, pollen, and certain food ingredients. Allergic rhinitis or hay fever occurs when the immune system overreacts to...

  • Allergy Drug
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • ALLERGY DRUGS
  • Allergy Drugs Sales Volume

This study focuses on China’s Allergy Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one...

  • Allergy Drug
  • China
  • Eisai Co., Ltd.
  • Sanofi-Synthelabo Inc.
  • Schering-Plough China Inc.
  • ALLERGY DRUGS
  • Allergy Drugs Industry Structure

China’s demand for Allergy Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Allergy Drug
  • China
  • Demand
  • Eisai Co., Ltd.
  • Schering-Plough China Inc.
  • IV. ALLERGY DRUGS PRODUCTION AND DEMAND
  • ALLERGY DRUGS IMPORT (BILLION YUAN)

This study focuses on China’s Allergy Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Allergy Drug
  • China
  • Demand
  • Market Size
  • Trade
  • Birch Pollen Allergy - Drug Profiles
  • VACCINE FOR BIRCH POLLEN ALLERGY - DRUG PROFILE

Birch Pollen Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Pipeline Review, H2 2018, provides an overview of the Birch Pollen Allergy (Immunology) pipeline landscape. Birch pollen allergy...

  • Allergy Drug
  • Europe
  • World
  • Product Initiative
  • Anergis SA
  • VACCINE FOR HOUSE DUST MITE ALLERGY - DRUG PROFILE
  • House Dust Mite Allergy - Drug Profiles

House Dust Mite Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Pipeline Review, H2 2018, provides an overview of the House Dust Mite Allergy (Immunology) pipeline landscape. House dust...

  • Allergy Drug
  • United States
  • World
  • Product Initiative
  • Anergis SA
  • Birch Pollen Allergy - Drug Profiles
  • LABORATORIOS LETI SL

Birch Pollen Allergy - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Pipeline Review, H1 2018, provides an overview of the Birch Pollen Allergy (Immunology) pipeline landscape. Birch pollen allergy...

  • Allergy Drug
  • Europe
  • World
  • Product Initiative
  • Anergis SA
  • VACCINE FOR PEANUT ALLERGY - DRUG PROFILE
  • VACCINE 2 FOR PEANUT ALLERGY - DRUG PROFILE

Peanut Allergy - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Pipeline Review, H2 2017, provides an overview of the Peanut Allergy (Immunology) pipeline landscape. Peanut allergy is common, especially in children. An allergic...

  • Allergy Drug
  • Therapy
  • United States
  • World
  • Product Initiative
  • Cedar Pollen Allergy - Drug Profiles
  • BIOLOGIC FOR CEDAR POLLEN ALLERGY - DRUG PROFILE

Cedar Pollen Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cedar Pollen Allergy - Pipeline Review, H2 2018, provides an overview of the Cedar Pollen Allergy (Immunology) pipeline landscape. Cedar allergy is a...

  • Allergy Drug
  • Therapy
  • Japan
  • World
  • Product Initiative
  • Cedar Pollen Allergy - Drug Profiles
  • BIOLOGIC FOR CEDAR POLLEN ALLERGY - DRUG PROFILE

Cedar Pollen Allergy - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cedar Pollen Allergy - Pipeline Review, H1 2018, provides an overview of the Cedar Pollen Allergy (Immunology) pipeline landscape. Cedar allergy is a...

  • Allergy Drug
  • Therapy
  • Japan
  • World
  • Product Initiative
  • Ragweed Pollen Allergy - Drug Profiles
  • BM-34 - DRUG PROFILE

Ragweed Pollen Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ragweed Pollen Allergy - Pipeline Review, H2 2018, provides an overview of the Ragweed Pollen Allergy (Immunology) pipeline landscape. Ragweed allergy...

  • Allergy Drug
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • VACCINE FOR PEANUT ALLERGY - DRUG PROFILE
  • VACCINE 2 FOR PEANUT ALLERGY - DRUG PROFILE

Peanut Allergy - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Pipeline Review, H1 2018, provides an overview of the Peanut Allergy (Immunology) pipeline landscape. Peanut allergy is common, especially...

  • Allergy Drug
  • Therapy
  • United States
  • Product Initiative
  • Aimmune Therapeutics, Inc.
  • ALLERGEN FOR ALLERGIC RHINITIS, ALLERGIC RHINO-CONJUNCTIVITIS AND BIRCH POLLEN ALLERGY - DRUG PROFILE
  • BILASTINE - DRUG PROFILE

Rhino-Conjunctivitis - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rhino-Conjunctivitis - Pipeline Review, H1 2018, provides an overview of the Rhino-Conjunctivitis (Ophthalmology) pipeline landscape. Rhinitis is characterized...

  • Allergy Drug
  • Therapy
  • United States
  • Product Initiative
  • Allergy Therapeutics plc
  • Grass Pollen Allergy - Drug Profiles
  • Vaccine for Grass Pollen Allergy - Drug Profile

Grass Pollen Allergy - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Grass Pollen Allergy - Pipeline Review, H1 2018, provides an overview of the Grass Pollen Allergy (Immunology) pipeline landscape. Grass pollen allergy...

  • Allergy Drug
  • Therapy
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • PL-101 - DRUG PROFILE
  • SHORT RAGWEED POLLEN (AMBROSIA ARTEMISIIFOLIA) ALLERGEN EXTRACT ODT - DRUG PROFILE

Food and Drug Administration (FDA) has approved RAGWITEK (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy Drug
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Grass Pollen Allergy - Drug Profiles
  • Regeneron Pharmaceuticals Inc

Grass Pollen Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Grass Pollen Allergy - Pipeline Review, H2 2018, provides an overview of the Grass Pollen Allergy (Immunology) pipeline landscape. Grass pollen allergy...

  • Allergy Drug
  • Therapy
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

Allergy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 ##.

  • Allergy Drug
  • OTC
  • APAC
  • World
  • Market Size
  • ALLERGEN FOR ALLERGIC RHINITIS, ALLERGIC RHINO-CONJUNCTIVITIS AND BIRCH POLLEN ALLERGY - DRUG PROFILE
  • SMALL MOLECULES TO AGONIZE TLR FOR SEASONAL ALLERGIC RHINITIS - DRUG PROFILE

Allergic Rhinitis - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Pipeline Review, H2 2018, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape. Allergic rhinitis is an allergic...

  • Allergy Drug
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • House Dust Mite Allergy - Drug Profiles
  • VACCINE FOR HOUSE DUST MITE ALLERGY - DRUG PROFILE

House Dust Mite Allergy - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Pipeline Review, H1 2018, provides an overview of the House Dust Mite Allergy (Immunology) pipeline landscape. House dust...

  • Allergy Drug
  • OTC
  • United States
  • World
  • Product Initiative
  • 2.5 Types of Allergy by Allergens
  • Types of Allergy

Scope of the Report The report titled “Global Allergy Immunotherapy Market (2017-2021 Edition)”, provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc. The report provides a regional analysis of the allergy immunotherapy market, including the following...

  • Allergy Drug
  • Allergy Immunotherapy
  • World
  • Market Size
  • Allergy Therapeutics plc
  • FEATURED NEWS & PRESS RELEASES
  • BILASTINE - DRUG PROFILE

The invention relates to preparation, pharmaceutical formulae of crystalline form ## of ##-[##-[##-[##-(##-ethoxyethyl)-##Hbenzimidazole-##-yl]-## -piperidinyl] ethyl]-alpha alpha-dimethyl-benzene acetic acid.

  • Allergy Drug
  • Dermatological Condition
  • Pharmaceutical
  • Therapy
  • Product Initiative

Additionally, unpredictable allergies (with potentially severe reactions) to drugs and biological agents are becoming problematic.

  • Allergy Drug
  • OTC
  • United States
  • World
  • Market Size
  • ALLERGEN FOR ALLERGIC RHINITIS AND RHINOCONJUNCTIVITIS - DRUG PROFILE
  • BILASTINE - DRUG PROFILE

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Allergy Drug
  • Therapy
  • United States
  • Product Initiative
  • Allergy Therapeutics plc
  • BIOSIMILAR FOR ALLERGY - DRUG PROFILE
  • ALLERGEN FOR ALLERGY - DRUG PROFILE

Hypersensitivity - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H2 2016’, provides an overview of the Hypersensitivity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hypersensitivity, complete with analysis...

  • Allergy Drug
  • Research And Development
  • United States
  • Company
  • Company Operations
  • form 1 of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1 -piperidinyl] ethyl]-alpha alpha-dimethylbenzene acetic acid.
  • BILASTINE - DRUG PROFILE

About ## percent of people who have food allergies are allergic to more than one food.

  • Allergy Drug
  • Therapy
  • Canada
  • United States
  • Product Initiative
  • Corporate Communications

He has previously spent over six years working at the US Food and Drug Administration (FDA) as a Medical Officer and Medical Team Leader in the Division of Pulmonary-Allergy Drug Products.

  • Allergy Drug
  • Europe
  • United States
  • Company Financials
  • Allergy Therapeutics plc
  • Allergy Therapeutics
  • ALK-Abello

The drug is indicated for individuals with type ## allergies of a perennial or seasonal nature.

  • Allergy Drug
  • World
  • Allergy Therapeutics plc
  • Merck & Co., Inc.
  • Stallergenes SA
  • ALLERGEN FOR RAGWEED POLLEN ALLERGY - DRUG PROFILE PRODUCT DESCRIPTION
  • Other Developmental Activities

Ragweed Allergy - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Ragweed Allergy - Pipeline Review, H1 2016’, provides an overview of the Ragweed Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ragweed Allergy, complete with analysis...

  • Allergy Drug
  • United States
  • World
  • Company Operations
  • Product Initiative
  • 5.1 INTRODUCTION

SOME COMMON TRIGGERS FOR DRUG ALLERGIES ARE PENICILLIN, SULFA DRUGS, ANTICONVULSANTS, ASPIRIN, IBUPROFEN, NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), AND CHEMOTHERAPY DRUGS.

  • Allergy Drug
  • North America
  • United States
  • Market Size
  • Danaher Corporation
  • Jun 06, 2017: Allergy Therapeutics: Directorate changes

Pharmaceutical companies spend US$## billion on an average and ## years to develop a new drug.

  • Allergy Drug
  • Europe
  • United States
  • Company Financials
  • Allergy Therapeutics plc